The Recall Desk

Hazard

Penicillin Cross Contamination recalls

315 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.

What the numbers show

Total
315
Critical
0
Severe
284
Most recent
2016-07-27

Of the 315 penicillin cross contamination recalls we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 284 (90%) are Severe.

About this hazard tag

Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all penicillin cross contamination recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.

A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.

251–275 of 315

  • SevereFDA (Drugs)·D-699-2015·2015-04-29

    Attix Pharmaceuticals Recalls Gemfibrozil Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling all lots of Gemfibrozil active pharmaceutical ingredient distributed between January 2012 and February 2015 due to potential penicillin cross-contamination.

    Product
    Gemfibrozil active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-712-2015·2015-04-29

    Attix Pharmaceuticals Recalls Hydrochlorothiazide Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Hydrochlorothiazide active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Hydrochlorothiazide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-744-2015·2015-04-29

    Attix Pharmaceuticals Recalls Ketotifen Fumarate Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling all lots of Ketotifen Fumarate active pharmaceutical ingredient distributed between January 5, 2012, and February 12, 2015, due to potential penicillin cross-contamination.

    Product
    Ketotifen Fumarate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-683-2015·2015-04-29

    Fluorexon API Recalled for Potential Penicillin Cross Contamination

    Attix Pharmaceuticals is recalling Fluorexon active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Fluorexon active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-757-2015·2015-04-29

    Attix Pharmaceuticals Recalls Levodopa API Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Levodopa active pharmaceutical ingredient lots distributed between January 2012 and February 2015 due to potential penicillin cross-contamination during repackaging.

    Product
    Levodopa or L-Dihydroxyphenylalanine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-923-2015·2015-04-29

    Attix Pharmaceuticals Recalls Tetracaine HCl Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Tetracaine HCl active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Tetracaine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-899-2015·2015-04-29

    Attix Pharmaceuticals Recalls Sodium Iodide Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Sodium Iodide active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Sodium Iodide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-504-2015·2015-04-29

    Attix Pharmaceuticals Recalls Albendazole Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Albendazole active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Albendazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-721-2015·2015-04-29

    Attix Pharmaceuticals Recalls Hydroxyprogesterone Caproate Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Hydroxyprogesterone Caproate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Hydroxyprogesterone Caproate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-517-2015·2015-04-29

    Attix Pharmaceuticals Recalls Amlodipine Due to Penicillin Cross Contamination Risk

    Attix Pharmaceuticals is recalling Amlodipine active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Amlodipine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-723-2015·2015-04-29

    Attix Pharmaceuticals Recalls Hydroxyurea Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Hydroxyurea active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Hydroxyurea active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-760-2015·2015-04-29

    Levosulpiride API Recalled for Potential Penicillin Cross Contamination

    Attix Pharmaceuticals is recalling Levosulpiride active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Levosulpiride active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-639-2015·2015-04-29

    Attix Pharmaceuticals Recalls Doxapram HCI Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Doxapram HCI Monohydrate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Doxapram HCI Monohydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-537-2015·2015-04-29

    Attix Pharmaceuticals Recalls Benazepril HCl Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Benazepril HCl active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Benazepril HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-587-2015·2015-04-29

    Attix Pharmaceuticals Recalls Cinacalcet HCI Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling all lots of Cinacalcet HCI active pharmaceutical ingredient distributed between January 5, 2012, and February 12, 2015, due to potential penicillin cross-contamination.

    Product
    Cinacalcet HCI active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-607-2015·2015-04-29

    Attix Pharmaceuticals Recalls Cyclosporine A Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Cyclosporine A active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Cyclosporine A active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-578-2015·2015-04-29

    Attix Pharmaceuticals Recalls Chlorobutanol Hemihydrate Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Chlorobutanol Hemihydrate pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Chlorobutanol Hemihydrate pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-822-2015·2015-04-29

    Attix Pharmaceuticals Recalls Olsalazine Sodium Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Olsalazine Sodium active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Olsalazine Sodium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-875-2015·2015-04-29

    Attix Pharmaceuticals Recalls Ranitidine HCl Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Ranitidine HCl active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Ranitidine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-729-2015·2015-04-29

    Attix Pharmaceuticals Recalls Idoxuridine Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Idoxuridine active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Idoxuridine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-548-2015·2015-04-29

    Attix Pharmaceuticals Recalls Bromhexine HCl Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling all lots of Bromhexine HCl active pharmaceutical ingredient distributed between January 5, 2012, and February 12, 2015, due to potential penicillin cross-contamination.

    Product
    Bromhexine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-694-2015·2015-04-29

    Attix Pharmaceuticals Recalls Furazolidine Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Furazolidine active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Furazolidine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-889-2015·2015-04-29

    Attix Pharmaceuticals Recalls Secretin Acetate Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Secretin Acetate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Secretin Acetate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-671-2015·2015-04-29

    Famciclovir Recalled Due to Potential Penicillin Cross Contamination

    Attix Pharmaceuticals is recalling famciclovir active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Famciclovir active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-934-2015·2015-04-29

    Attix Pharmaceuticals Recalls Tolfenamic Acid Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Tolfenamic Acid active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Tolfenamic Acid active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide